why choose us

First received: September 01, 2023

Clinical Trial: An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Metastatic Colorectal Cancer

Study Type: OBSERVATIONAL


Official Title: Real-world Study in Metastatic Colorectal Cancer Patients With Long-term Responses to Regorafenib in the US

Brief Summary: This is an observational study in which data already collected from patients with metastatic colorectal cancer will be studied.Metastatic colorectal cancer (mCRC) is a cancer of the colon (large bowel) or the rectum (lowest part of the bowel just before the anus) that has spread to other parts of the body.The study drug, regorafenib, is already approved for cancer doctors to prescribe to patients with mCRC.It is an anti-cancer drug that blocks several proteins, called enzymes, which are involved in the growth of…

Read more